Sean E. Browne - 15 Oct 2021 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Reporting relationship: President and CEO, Director
Issuer ticker: XTNT
Reported as of: 15 Oct 2021
Net transaction value: -$177,843
SEC form: 4
Accepted by SEC: 18 Oct 2021, 16:21:57 UTC
Next SEC filing: 20 Oct 2022
Source filing: View source filing
Reporting owner signature: /s/ Amy Culbert, attorney-in-fact

Key filing fact

Sean E. Browne filed Form 4 for Xtant Medical Holdings, Inc. (XTNT) on 18 Oct 2021.

Key facts

This page summarizes Sean E. Browne's Form 4 filing for Xtant Medical Holdings, Inc. (XTNT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Oct 2021, 16:21.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: -$177,843.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XTNT transaction

Common Stock, $0.000001 par value

Tax liability

Transaction value: $177,843
Shares: -160,219
Change %: -8.9%
Price: $1.11
Shares after: 1,637,684
Date: 15 Oct 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes 197,426 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan and 1,101,644 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan.